Nirvana Life Sciences Inc.
NIRVX
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.20K | -65.50K | -26.50K | -119.60K | -55.30K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.70K | -400.00 | -100.00 | 11.10K | -137.80K |
| Change in Net Operating Assets | 34.30K | 20.80K | -668.60K | 90.50K | 65.40K |
| Cash from Operations | -3.20K | -45.10K | -695.20K | -18.00K | -127.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 5.00K | 61.60K | 5.00K | 70.20K | 43.00K |
| Total Debt Repaid | -- | -- | -- | 85.80K | -- |
| Issuance of Common Stock | 0.00 | 0.00 | 950.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.20K | 0.00 | -800.00 | -- | -- |
| Cash from Financing | 4.60K | 44.40K | 694.50K | 109.80K | 30.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -1.70K | 700.00 | -- | -84.70K | 92.50K |
| Net Change in Cash | -400.00 | 100.00 | -700.00 | 7.10K | -4.90K |